
    
      Subjects who received complete full vaccination with Henogen HBV adjuvanted vaccine or
      Fendrixâ„¢ will participate in this persistence study for three long-term time points (12, 24
      and 36 months after the first dose of primary vaccination). Blood sampling will be done at
      each time point to measure immune persistence.
    
  